The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Dambkowski Carl since 2024.
This trader's CIK number is 1983476.
At the time of last reporting, Dambkowski Carl was the Director of Oruka Therapeutics, Inc.. (stock ticker symbol ORKA).
Also see all insider trading activities at Oruka Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | ORKA | 0 | $0 | 105,000 | $6,212,430 | 62,260 | $548,074 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | APGE | 0 | $0 | 40,700 | $3,163,501 | 30,525 | $697,799 |
| 2025 | APGE | 0 | $0 | 51,305 | $2,608,498 | 18,605 | $425,308 |
| 2024 | APGE | 0 | $0 | 44,530 | $2,151,747 | 1,815 | $41,490 |
1. Oruka Therapeutics, Inc. (ORKA)
2. Apogee Therapeutics, Inc. (APGE)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-05-21 | ORKA | Sale | 105,000 | 59.17 | 6,212,430 |
| 2026-05-21 | ORKA | Option Ex | 62,260 | 8.80 | 548,074 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-05-06 | APGE | Option Ex | 4,125 | 22.86 | 94,297 |
| 2026-05-06 | APGE | Sale | 5,500 | 84.26 | 463,430 |
| 2026-04-01 | APGE | Sale | 5,500 | 85.18 | 468,473 |
| 2026-04-01 | APGE | Option Ex | 4,125 | 22.86 | 94,297 |
| 2026-03-04 | APGE | Sale | 5,500 | 71.86 | 395,213 |
| 2026-03-04 | APGE | Option Ex | 4,125 | 22.86 | 94,297 |
| 2026-02-04 | APGE | Sale | 5,500 | 66.88 | 367,818 |
| 2026-02-04 | APGE | Option Ex | 4,125 | 22.86 | 94,297 |
| 2026-01-07 | APGE | Option Ex | 14,025 | 22.86 | 320,611 |
| 2026-01-07 | APGE | Sale | 18,700 | 78.53 | 1,468,567 |
| 2025-12-04 | APGE | Sale | 10,900 | 75.00 | 817,500 |
| 2025-11-05 | APGE | Option Ex | 8,060 | 22.86 | 184,251 |
| 2025-11-05 | APGE | Sale | 10,785 | 55.13 | 594,630 |
| 2025-10-01 | APGE | Option Ex | 2,385 | 22.86 | 54,521 |
| 2025-10-01 | APGE | Sale | 5,110 | 39.80 | 203,378 |
| 2025-08-06 | APGE | Sale | 2,725 | 37.78 | 102,950 |
| 2025-07-02 | APGE | Option Ex | 7,365 | 22.86 | 168,363 |
| 2025-07-02 | APGE | Sale | 10,090 | 45.51 | 459,165 |
| 2025-05-07 | APGE | Sale | 2,725 | 35.75 | 97,418 |
| 2025-04-02 | APGE | Sale | 3,860 | 36.73 | 141,766 |
| 2025-03-05 | APGE | Sale | 1,590 | 30.48 | 48,463 |
| 2025-02-05 | APGE | Option Ex | 795 | 22.86 | 18,173 |
| 2025-02-05 | APGE | Sale | 3,520 | 40.69 | 143,228 |
| 2024-12-11 | APGE | Sale | 4,540 | 49.31 | 223,867 |
| 2024-12-11 | APGE | Option Ex | 1,815 | 22.86 | 41,490 |
| 2024-12-04 | APGE | Sale | 6,665 | 46.07 | 307,056 |
| 2024-11-06 | APGE | Sale | 6,665 | 59.44 | 396,134 |
| 2024-10-02 | APGE | Sale | 6,665 | 56.51 | 376,639 |
| 2024-09-04 | APGE | Sale | 6,665 | 47.77 | 318,420 |
| 2024-08-07 | APGE | Sale | 7,335 | 41.37 | 303,470 |
| 2024-07-03 | APGE | Sale | 5,995 | 37.73 | 226,161 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dambkowski Carl (Director of Oruka Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.